AI Article Synopsis
- Acute megakaryoblastic leukemia (AMKL) in children without Down syndrome has a low 3-year survival rate of under 40%, whereas those with Down syndrome achieve much better outcomes.
- A new genetic translocation involving the CBFA2T3 and GLIS2 genes is found in about 30% of non-DS AMKL cases, and this fusion gene indicates a worse prognosis for affected children.
- The article discusses the challenging clinical experiences of pediatric patients diagnosed with AMKL who carry the CBFA2T3-GLIS2 fusion gene.
Article Abstract
Acute megakaryoblastic leukemia (AMKL) in children without Down syndrome (DS) has an extremely poor outcome with 3-year survival of less than 40%, whereas AMKL in children with DS has an excellent survival rate. Recently, a novel recurrent translocation involving CBFA2T3 and GLIS2 was identified in about 30% of children with non-DS AMKL, and the fusion gene was reported as a strong poor prognostic factor in pediatric AMKL. We report the difficult clinical courses of pediatric patients with AMKL harboring the CBFA2T3-GLIS2 fusion gene.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204189 | PMC |
| http://dx.doi.org/10.4274/tjh.2016.0008 | DOI Listing |
Publication Analysis
Top Keywords
fusion gene
12
clinical courses
8
courses pediatric
8
pediatric patients
8
acute megakaryoblastic
8
megakaryoblastic leukemia
8
harboring cbfa2t3-glis2
8
cbfa2t3-glis2 fusion
8
amkl children
8
amkl
5
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!